The global market size for molecular spectrometry is expected to grow at a CAGR of 7.22% from 2024 to 2029 and be worth USD 11.84 billion by 2029 from USD 8.35 billion in 2024.
Molecular spectroscopy is a branch of quantum physics that deals with the interaction of electromagnetic radiation with materials to produce a spectrum, which can be used to deduce structural or compositional information. Infrared (IR) spectroscopy uses stimulation of molecular movement or vibration, while ultraviolet/visible spectroscopy uses the excitation of an electron in a higher orbital. Spectroscopy is one of the most advanced and well-known analytical techniques, with applications ranging from healthcare to industry. The measurement of the interaction between radiated energy emitted by certain substances is called spectroscopy.
Food safety concerns, the pharmaceutical and biotechnology industries' growth, technological advancements in molecular spectroscopy, and the use of molecular spectroscopy in environmental screening are a few factors promoting the development of the global molecular spectrometry market. Near-infrared spectroscopy is one of the molecular spectroscopy types used in the R&D of pharmaceuticals and other biotechnology products. It is one of the molecular spectroscopy types utilized in R&D. NIR spectroscopy has acquired widespread acceptance in the pharmaceutical sector in recent years as a result of its significant benefits over other analytical techniques, such as ease of sample preparation and the ability to predict chemical and physical sample properties from a single spectrum. As a result, there has been a lot of talk about how people are becoming more interested in this technology, which might help the market grow.
Rapid improvements in the healthcare and life sciences industries have a more significant impact on the growth rate of the global molecular spectroscopy market. It's being used to investigate structural activity relationships and improve reaction conditions and other parameters like polymorph and formulation screening, all of which contribute to the scaling up needed to get therapeutic compounds from discovery to development. As a result, the market is expected to rise substantially during the forecast period. Furthermore, during the forecast period, the rise in new product releases and partnerships and growing new markets would give advantageous opportunities for the growth of the global molecular spectroscopy market. In addition, medical tourism is on the rise, and pharmaceutical companies emphasize discovering new compounds, which leads to more profitable growth opportunities.
The high cost of equipment and higher research & development expenditures is projected to limit market expansion during the forecast period. Furthermore, due to a significant shortage of skilled personnel for method development, operation, validation, and troubleshooting activities, Unfavorable economic conditions and political instability may cause a drop in product sales and demand, affecting the molecular spectroscopy market's optimum growth potential in the coming years. On the other hand, the influence of the COVID-19 pandemic on the supply chain and an unfavorable reimbursement scenario will act as a restraint on the market's growth rate from 2024 to 2029.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Technology, Application & Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Key Market Players |
Thermo Fisher Scientific, Inc., Merck KGaA, PerkinElmer Inc. |
Over the forecast period, the NMR Spectroscopy segment is expected to grow at a healthy rate. In quality control and research, nuclear magnetic resonance (NMR) spectroscopy is an analytical chemistry technique for assessing the quantity and purity of a sample and its molecular structure. NMR spectroscopy has the advantage of requiring minimal sample preparation and being a non-destructive technology that preserves the molecules being studied.
The pharmaceutical application is predicted to expand at the fastest CAGR throughout the forecast period. The rising importance of molecular spectroscopy in various stages of drug discovery and increased R&D in pharmaceutical firms are driving this expansion.
Due to the increased use of molecular spectroscopy in the pharmaceutical industry, more significant financing for environmental testing, rising worries about food safety, and favorable government efforts and legislation, North America is expected to be leading the global market. In addition, the United States boasts the world's most supportive domestic environment for pharmaceutical research, development, and commercialization, with few market restrictions. As a result, spectroscopy in drug discovery and development in the United States is projected to increase in the coming years. Many pharmaceutical companies are present in Canada, and they continue to play an important role.
The regional market for molecular spectroscopy in Europe, which includes Germany, Spain, France, and the United Kingdom, is experiencing incremental development, making Europe the second-largest market worldwide. The growing presence of global leaders and significant pharmacy companies in the region will continue to drive the expansion of the European markets.
As the market set up in growing countries such as China and India opens new windows of opportunity, Asia Pacific is also producing new opportunities for stakeholders. The region's need for a wide range of molecular spectroscopy equipment is projected to stay high. Accelerating medical-related research and development efforts in Japan could also be a strong growth driver.
Thermo Fisher Scientific, Inc., Merck KGaA, PerkinElmer Inc., ABB, Agilent Technologies, Inc., Bruker, Horiba, Ltd, Shimadzu Corporation, JEOL Ltd, and JASCO are some of the promising companies operating in the global molecular spectrometry market profiled in this report.
This research report on the global molecular spectrometry market has been segmented and sub-segmented based on technology, application & region.
By Technology
By Application
By Region
Frequently Asked Questions
The global molecular spectrometry market is expected to be worth USD 7.79 billion in 2023.
Some of the major players in the molecular spectrometry market include Agilent Technologies, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, and Shimadzu Corporation, among others.
Some of the emerging trends in the molecular spectrometry market include the development of miniaturized and portable instruments, the increasing use of artificial intelligence and machine learning in data analysis, and the growing adoption of ambient ionization techniques in mass spectrometry.
The COVID-19 pandemic has led to increased demand for molecular spectrometry in the development of vaccines and therapeutics, as well as in the testing and analysis of patient samples. However, the pandemic has also resulted in disruptions to global supply chains and delays in research activities, which could impact the market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region